【基因組醫學．建立】

葉玉如教授
香港科技大學晨興生命科學教授
國際知名神經生物學家
葉教授在專訪中分享道，先進的基因組測序技術，對研究阿爾茲海默症（Alzheimer's Disease，AD）這類與遺傳有關的疾病，意義重大。她指出，「遺傳因素」可以解釋到大約七成AD 的成因。但在不同族群中，「遺傳因素」對疾病會有不同的影響；而在全球醫學研究中，卻十分缺乏中國人相關的基因組數據庫。因此，建立本地人口的基因組數據庫對診斷AD和制訂治療方案，均有莫大幫助。
葉教授亦認為，香港擁有完善的醫療系統及頂尖的科研人才，香港基因組中心可善用現有平台推動基因組研究，建立本地人口的基因組數據庫，加深了解疾病和基因突變的的關係。此外，透過科學研究，亦可為不同疾病尋找診斷和治療方法，讓大眾受惠，並為香港，內地以至整個亞洲的醫學界作出貢獻。
了解更多香港基因組中心及計劃，請瀏覽：www.hkgp.org
【Genomic Medicine．Building The Blocks】
Professor Nancy Ip
The Morningside Professor of Life Science, HKUST
World-renowned Neuroscientist
In the interview, Professor Ip commented that advancement in genome sequencing technology takes on added importance in the research of AD and other genetic diseases. She explained that genetic factors account for around 70% of AD cases; yet the impact of genetic factors varies between ethnic groups. Given the lack of genomic data of the Chinese populations in today’s scientific community worldwide, building a genome database will be crucial for the diagnosis and treatment for AD patients.
Professor Ip also shared that with Hong Kong’s world-class healthcare system and top-notch R&D talents, HKGI could leverage the city’s long-standing edges and resources to drive scientific research in genomics and the establishment of a genome database of local populations to facilitate better understanding of the relationship between diseases and genetic mutations. Relevant research and discoveries will not only benefit the general public in the search of diagnosis and treatment plans for various diseases, but also contribute to the scientific and medical community in Hong Kong, the Mainland and the entire region of Asia.
To learn more about Hong Kong Genome Institute and Hong Kong Genome Project, please visit: hkgp.org/en
#香港基因組中心 #香港基因組計劃 #全基因組測序 #未能確診病症 #遺傳性癌症 #基因組醫學 #阿爾茲海默症 #認知障礙症 #腦退化症 #基因組數據庫 #基因組數據 #葉玉如 #hkgi #hkgp #WholeGenomeSequecing #UndiagnosedDiseases #HereditaryCancer #GenomicMedicine #AlzheimersDisease #Dementia #GenomeDatabase #GenomicData #NancyIp